Visual Attention Span Mobilisation for Dyslexia

Dyslexia Clinical Trial

Official title: Maevad - Mobilisation Active de l'Empan Visuo-Attentionel Pour la Dyslexie

Status Completed

Clinical Trial Summary

The aim of the study is to evaluate the efficiency of the medical device MAEVAD in improving the reading skills of children with dyslexia.

Clinical Trial Description

MAEVAD is a digital therapy specifically designed to improve the visual attention (VA) span of children with dyslexia. Dyslexia is characterized by a specific and significant impairment in reading and/or writing production and spelling. Some profiles of children with dyslexia show a deficit in VA span, characterized by a decrease in the number of distinct visual elements that can be processed simultaneously. VA span plays a critical role in the acquisition of reading skills and specific knowledge of word spelling. Brain regions involved in visual-attentional skills are under-activated in dyslexic children with VA deficits and can be reactivated following specific and intensive VA span training.

In this study 150 children with dyslexia will be randomized in tow groups. On the first group children will be trained first with MAEVAD then with a control training that does not stimulate the VA span. On contrary, on the second group children will first perform the control training and then MAEVAD.

For each intervention the sessions will lasts 15 minutes. 5 sessions are planned per weeks for 6 weeks. ;

Related Conditions & MeSH terms

• Dyslexia

• NCT number: NCT05201235
• Study type: Interventional
• Source: Humans Matter
• Status: Completed
• Phase: N/A
• Start date: January 17, 2022
• Completion date: July 5, 2023